Akalushi Muthukumarana

Statistics

Publications

Citations

190

H-Index

Active since

2011

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (France)

Boehringer Ingelheim (Japan)

Akalushi Muthukumarana is an author at Boehringer Ingelheim (United States) specializing in pharmacology, cardiovascular pharmacology, and cardiovascular pharmacodynamics.

Publications per year

2011–2014

Publications

The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat

Ryan M. Fryer, Akalushi Muthukumarana, Paul C. Harrison et al. · PLoS ONE · 2012 · 79 citations · Full text

Medicine, Pharmacology, Physiology +17

G Protein–Coupled Bile Acid Receptor 1 Stimulation Mediates Arterial Vasodilation through a KCa1.1 (BKCa)–Dependent Mechanism

Ryan M. Fryer, Khing Jow Ng, Suzanne G. Nodop Mazurek et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 43 citations

Life Sciences, Pharmacology, Physiology +14

Functional biomarkers of musculoskeletal syndrome (MSS) for early in vivo screening of selective MMP-13 inhibitors

Suzanne G. Nodop Mazurek, Jun Li, Gerald Nabozny et al. · Journal of Pharmacological and Toxicological Methods · 2011 · 21 citations

Medicine, Orthopedic Surgery, Pharmacology +14

Mitigation of Off-Target Adrenergic Binding and Effects on Cardiovascular Function in the Discovery of Novel Ribosomal S6 Kinase 2 Inhibitors

Ryan M. Fryer, Akalushi Muthukumarana, Rong Rhonda Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 18 citations

Medicine, Medicinal Chemistry, Pharmacology +17

CCR1 Plays a Critical Role in Modulating Pain through Hematopoietic and Non-Hematopoietic Cells

Nuruddeen D. Lewis, Akalushi Muthukumarana, Steven E. Fogal et al. · PLoS ONE · 2014 · 18 citations · Full text

Life Sciences, Immunology, Pharmacology +17

1–5 of 6